Immunovant, Inc.
IMVT · NASDAQ
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$413,840 | -$259,336 | -$210,960 | -$156,730 |
| Dep. & Amort. | $377 | $231 | $193 | $126 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $49,487 | $41,116 | $32,296 | $34,244 |
| Change in WC | -$12,031 | $2,632 | -$10,853 | $15,142 |
| Other Non-Cash | $133 | $1,130 | $1,131 | $1,106 |
| Operating Cash Flow | -$375,874 | -$214,227 | -$188,193 | -$106,112 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$759 | -$360 | -$197 | -$254 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$759 | -$360 | -$197 | -$254 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $450,000 | $472,745 | $70,500 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $4,492 | -$318 | $385 | $200,129 |
| Financing Cash Flow | $454,492 | $472,427 | $70,885 | $200,129 |
| Forex Effect | $747 | $993 | $220 | -$92 |
| Net Chg. in Cash | $78,606 | $258,833 | -$117,285 | $93,671 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $635,365 | $376,532 | $493,817 | $400,146 |
| End Cash | $713,971 | $635,365 | $376,532 | $493,817 |
| Free Cash Flow | -$376,633 | -$214,587 | -$188,390 | -$106,366 |